Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 256.78B P/E 19.36 EPS this Y 16.30% Ern Qtrly Grth 24.20%
Income 13.34B Forward P/E 12.45 EPS next Y -15.30% 50D Avg Chg -8.00%
Sales 57.82B PEG -3.65 EPS past 5Y 18.82% 200D Avg Chg -3.00%
Dividend 4.00% Price/Book 16.05 EPS next 5Y -2.92% 52W High Chg -17.00%
Recommedations 2.30 Quick Ratio 0.69 Shares Outstanding 1.77B 52W Low Chg 8.00%
Insider Own 0.11% ROA 9.27% Shares Float 1.77B Beta 0.62
Inst Own 70.92% ROE 90.65% Shares Shorted/Prior 11.96M/13.58M Price 145.20
Gross Margin 69.83% Profit Margin 23.19% Avg. Volume 5,445,468 Target Price 162.96
Oper. Margin 37.21% Earnings Date Feb 9 Volume 5,435,918 Change 0.25%
About AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

ABBV Chatroom

User Image rahagar Posted - 27 minutes from now

$ABBV back to longer term TL support. Daily chart looking like it is bottoming here. Here's weekly chart. ER next week on Feb 9, BMO.

User Image 70W304Speed Posted - 23 minutes from now

$AMC $APE Want to see how it feels hedgies when it's not one of your bought and paid for media plebes? SHORT $ABT And $ABBV you're welcome. 🖕 https://youtu.be/3L4YrGaR8E4

User Image topstockalerts Posted - 7 minutes ago

Recession Risk Fades, and Speculation Returns—For Now $DIS $NFLX $ABBV https://www.marketwatch.com/articles/recession-risk-fades-and-stock-market-speculation-returns-51675467601?mod=barrons-on-marketwatch

User Image Newsfilter Posted - 55 minutes ago

Recession Risk Fades, and Speculation Returns—For Now $DIS $NFLX $ABBV $PEP https://newsfilter.io/a/89a551443957a3f77d4ea850fb59ec0c

User Image STCKPRO Posted - 2 hours ago

$ABBV NEW ARTICLE : Pfizer: The Covid Reset Makes Sense https://www.stck.pro/news/ABBV/41842207

User Image tickeron Posted - 3 hours ago

If you have $ABBV or $NVO in your portfolio, pay attention! #ABBVIE https://srnk.us/go/4373323

User Image WBiden Posted - 3 hours ago

$ABBV LOL

User Image B_Akhenaten Posted - 5 hours ago

$ABBV Daily Dump for this one

User Image fishinNbanjo Posted - 5 hours ago

$ABBV is it ever bottoming? Lol

User Image WBiden Posted - 5 hours ago

$ABBV feels dumpy. Algos must still be on. Moves the same everyday.

User Image Rocky998 Posted - 5 hours ago

$ABBV hoping to see $160 by this time next week

User Image Ineedamilibucks Posted - 6 hours ago

$ABBV sell sell sell screams this stock

User Image Newsfilter Posted - 6 hours ago

Cigna expects revenue gains from launches of Humira biosimilars $CI $ABBV $AMGN $CNC https://newsfilter.io/a/b4c6c9405f6ffcff3a215bd0c7523623

User Image GeorgeTheo Posted - 6 hours ago

$BMY $MRK $SLS $ABBV

User Image RyanOwensk Posted - 6 hours ago

$ROOT $PCG $ABBV GOOD QUESTION!! ↳ Why are you paying to be in a Trading Room? FREE Trading Room via (Google Search)⟶ 𝐟𝐫𝐞𝐞𝐚𝐥𝐞𝐫𝐭.𝐩𝐰

User Image Ineedamilibucks Posted - 6 hours ago

$ABBV 144 bearish!!!

User Image tickeron Posted - 7 hours ago

What is the difference between $ABBV and $GILD? Learn it. #ABBVIE https://srnk.us/go/4372780

User Image STCKPRO Posted - 8 hours ago

$ABBV NEW ARTICLE : If You Want Tons of Passive Income in the Future , Buy These 2 Stocks https://www.stck.pro/news/ABBV/41829360

User Image SweepCast Posted - 8 hours ago

SweepCast ⚡ Unusual Options Detected: $ABBV with Unusual Options Activity Alerted on $180 PUT Expiring: 02-17-2023 worth 35K🐻 |🥇 Start Using SweepCast! @SweepCast 🥇 |

User Image BenjiOskar Posted - 9 hours ago

$UBX we are near the 200 daily trend line and you know what this means! Take off is near to new highs lfg $NVAX $ABBV $MRK $GILD

User Image kinderspiel Posted - 9 hours ago

$CAH reports q2 eps $1.32, consensus $1.14, raises fy23 eps view to $5.20-$5.50 from $5.05-$5.40 $WBD reaches deals with $ROKU & $FOX’s tubi for fast channels $ABBV humira drug faces competition in the US #FTCH partnership deal w/ luxury fashion house richemont acquires 47.5% stake in ynap (yoox, net-a-porter) + 12 richemont brands. farfetch (double moving average crossover, 38% of current book value) consolidates control of ecommerce distribution into ‘hard luxury’ game (cartier, van cleef & arpels, piaget & buccellatti) strategic investors (conde nast, chanel) & asian (jd) acquisitions (brown’s, stadium goods, new guards group)

User Image stockilluminati Posted - 10 hours ago

$ABBV https://www.stockilluminati.com/abbv/display.php?url=https://clinicaltrials.gov/ct2/show/NCT05711394 - trial update posted here!

User Image R33dh Posted - 10 hours ago

$ABBV Sold for the time being, keish is better spent elsewhere. I don't believe i'll miss out on anything for a bit. Hoping to buy back in the 120s/30s.

User Image STCKPRO Posted - 10 hours ago

$ABBV NEW ARTICLE : 2 Steady Stocks to Buy in a Recession https://www.stck.pro/news/ABBV/41826944

User Image Alexhere Posted - 10 hours ago

$ENDPQ Bidding war coming soon 💲✍️💲✍️💲💉💊 $ABBV $JNJ Heading into 2022, top drugmakers had $1.7 trillion in dealmaking firepower, fueling expectations that the industry was due for a gangbuster year of M&A activity.

User Image Alexhere Posted - 10 hours ago

$ENDPQ $BMY $ABBV Of course, 2019 represented a high-water mark for dealmaking. Early that year, Bristol Myers Squibb spent $74 billion to acquire Celgene. Months later, AbbVie laid out around $63 billion for Allergan. Those two major deals haven’t been rivaled since.

User Image crtlabz Posted - 11 hours ago

$ABBV in trouble sub-$143. best of the bios

User Image stockilluminati Posted - 18 hours ago

$ABBV https://www.stockilluminati.com/abbv/news.php - Compounders And Dividends: January 2023 Portfolio Update

User Image janthony23 Posted - 20 hours ago

$ABBV Wow! What’s a great time to buy!

User Image GeorgeTheo Posted - 1 day ago

$SLS Trading activity to pin this down is typical of a market player trying to keep the price down for a buyout. Def Looks Like $MRK $BMY or $ABBV. They’re all on the hunt for new drugs and combo agents. -

Analyst Ratings
Piper Sandler Overweight Jan 17, 23
Morgan Stanley Overweight Dec 6, 22
Credit Suisse Outperform Nov 18, 22
Societe Generale Hold Nov 8, 22
Atlantic Equities Neutral Oct 31, 22
Morgan Stanley Overweight Oct 31, 22
BMO Capital Outperform Oct 31, 22
Barclays Equal-Weight Oct 31, 22
Morgan Stanley Overweight Oct 11, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Option 104.59 79,801 8,346,387 231,904 05/25/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Sell 151.16 79,801 12,062,719 152,103 05/25/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Option 54.86 83,960 4,606,046 125,583 05/20/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Sell 155 83,960 13,013,800 41,623 05/20/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Option 78.23 200,000 15,646,000 252,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Sell 154.58 200,000 30,916,000 152,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Option 57.21 300,000 17,163,000 252,103 05/10/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Sell 151.2 300,000 45,360,000 152,103 05/10/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Option 58.88 27,690 1,630,387 88,631 03/25/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Sell 159.2 27,690 4,408,248 60,941 03/25/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Option 79.02 11,682 923,112 37,722 03/11/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Sell 150 18,628 2,794,200 19,094 03/11/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Mar 01 Sell 148.12 25,000 3,703,000 16,623 03/02/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Feb 25 Sell 148.43 15,000 2,226,450 41,623 03/01/22
Michael Robert A. Vice Chairman Vice Chairman Feb 25 Sell 148.32 43,105 6,393,334 37,877 03/01/22
Strom Carrie C SVP & Pres Global Al.. SVP & Pres Global Allerg Aesth Feb 07 Sell 141.17 2,396 338,243 42,499 02/08/22
AUSTIN ROXANNE S Director Director Nov 02 Sell 116.42 71,844 8,364,078 49,284 11/04/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Sell 120 13,080 1,569,600 11,595 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Option 114.36 7,080 809,669 18,675 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Option 86.26 20,195 1,742,021 52,946 02/24/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Sell 105 20,195 2,120,475 32,751 02/24/21
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Option 51.42 51,990 2,673,326 51,990 12/01/20
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Sell 105 51,990 5,458,950 12/01/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Option 24.21 4,800 116,208 118,667 11/12/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Sell 93.61 4,800 449,328 113,867 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Option 56.87 194,154 11,041,538 512,796 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Sell 96.76 231,604 22,410,003 318,642 11/12/20